Iconiq Capital, LLC Relay Therapeutics, Inc. Transaction History
Iconiq Capital, LLC
- $4.6 Billion
- Q3 2024
A detailed history of Iconiq Capital, LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Iconiq Capital, LLC holds 94,697 shares of RLAY stock, worth $453,598. This represents 0.01% of its overall portfolio holdings.
Number of Shares
94,697
Previous 94,697
-0.0%
Holding current value
$453,598
Previous $617,000
8.59%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding RLAY
# of Institutions
201Shares Held
156MCall Options Held
192KPut Options Held
40K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$134 Million1.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.5MShares$69.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$50.5 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY9.25MShares$44.3 Million5.09% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.38MShares$35.3 Million0.88% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $576M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...